Patents by Inventor Michael Graige

Michael Graige has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240044909
    Abstract: The present disclosure relates to compositions of matter, methods, and systems for analyzing polymeric macromolecules, including polymeric macromolecules such as peptides, polypeptides, and proteins.
    Type: Application
    Filed: August 3, 2023
    Publication date: February 8, 2024
    Inventors: Michael Graige, Christopher MacDonald
  • Patent number: 11685889
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Grant
    Filed: April 30, 2022
    Date of Patent: June 27, 2023
    Assignee: INSCRIPTA, INC.
    Inventors: Andrew Garst, Richard Fox, Eileen Spindler, Amy Hiddessen, Phillip Belgrader, Don Masquelier, Bruce Chabansky, Michael Graige
  • Publication number: 20230149933
    Abstract: An array including a solid support having a plurality of contours along its exterior surface. A first subset of contours is positioned along the exterior surface of the solid support to form a first pattern of features and a second subset of contours is positioned along the exterior surface to form a second pattern of features. The contours of the first subset are juxtaposed with the second subset along the exterior surface, whereby the first and second patterns form an interleaved pattern. The features of the first pattern occur at a first elevation z1 and the features of the second pattern occur at a second elevation z2. The features of the first pattern are configured to attach analytes at a different elevation relative to analytes attached to the features of the second pattern.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 18, 2023
    Inventors: M. Shane Bowen, Michael Graige, Stanley S. Hong, John A. Moon, Merek Siu
  • Patent number: 11555184
    Abstract: The present disclosure methods for identifying binding partners using cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of peptides that bind to targets of interest. The engineered peptides are preferably expressed in the cells under conditions that provide both secretion and display of the engineered peptides on the cell surfaces, thus providing access of the engineered peptides to identify potential binding pairs. The cell libraries cab be engineered using an automated editing system that provides for one or more targeted edits per cell.
    Type: Grant
    Filed: August 9, 2020
    Date of Patent: January 17, 2023
    Assignee: Inscripta, Inc.
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Publication number: 20220349091
    Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 3, 2022
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Patent number: 11473214
    Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: October 18, 2022
    Assignee: Inscripta, Inc.
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Publication number: 20220259543
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Application
    Filed: April 30, 2022
    Publication date: August 18, 2022
    Inventors: Andrew Garst, Richard Fox, Eileen Spindler, Amy Hiddessen, Phillip Belgrader, Don Masquelier, Bruce Chabansky, Michael Graige
  • Publication number: 20220243361
    Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 4, 2022
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Patent number: 11396718
    Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: July 26, 2022
    Assignee: Inscripta, Inc.
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Publication number: 20220195625
    Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.
    Type: Application
    Filed: March 9, 2022
    Publication date: June 23, 2022
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Patent number: 11365383
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Grant
    Filed: February 21, 2022
    Date of Patent: June 21, 2022
    Assignee: Inscripta, Inc.
    Inventors: Eileen Spindler, Amy Hiddessen, Andrew Garst, Michael Graige, Richard Fox, Phillip Belgrader, Don Masquelier, Bruce Chabansky
  • Publication number: 20220177826
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Application
    Filed: February 21, 2022
    Publication date: June 9, 2022
    Inventors: Eileen Spindler, Amy Hiddessen, Andrew Garst, Michael Graige, Richard Fox, Phillip Belgrader, Don Masquelier, Bruce Chabansky
  • Patent number: 11293117
    Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: April 5, 2022
    Assignee: Inscripta, Inc.
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige
  • Patent number: 11268061
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: March 8, 2022
    Assignee: Inscripta, Inc.
    Inventors: Andrew Garst, Michael Graige, Richard Fox, Eileen Spindler, Amy Hiddessen, Phillip Belgrader, Don Masquelier, Bruce Chabansky
  • Publication number: 20220002725
    Abstract: The present disclosure relates to compositions, methods, modules and automated, integrated instrumentation to enable nucleic acid-guided nuclease or nickase fusion editing in cells and correlating the edits to the resulting cellular nucleic acid profile. In some embodiments, methylated bases in a repair template are substituted for unmethylated bases in the cellular target genome and in some embodiments, unmethylated bases are substituted for methylated bases in the cellular target genome.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 6, 2022
    Inventors: Stephen Tanner, Michael Graige, Nandini Krishnamurthy, Craig Struble
  • Publication number: 20220002755
    Abstract: The present disclosure relates to compositions, methods, modules and automated integrated instrumentation to make auxiliary or ancillary edits—in addition to intended edits and immunizing edits—in cellular genomic nucleic acids in order to assess and improve nucleic acid-guided nuclease or nickase fusion editing.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 6, 2022
    Inventors: Stephen Tanner, Michael Graige, Craig Struble, Nandini Krishnamurthy, Andrea Halweg-Edwards, Bryan Leland, Simon Cawley, Joshua Shorenstein, Timothy Shaver
  • Publication number: 20210371799
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Application
    Filed: August 13, 2021
    Publication date: December 2, 2021
    Inventors: Andrew Garst, Michael Graige, Richard Fox, Eileen Spindler, Amy Hiddessen, Phillip Belgrader, Don Masquelier, Bruce Chabansky
  • Patent number: 11142740
    Abstract: The present disclosure provides automated modules and instruments for improved detection of nuclease genome editing of live cells. The disclosure provides improved modules—including high throughput modules—for screening cells that have been subjected to editing and identifying and selecting cells that have been properly edited.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: October 12, 2021
    Assignee: Inscripta, Inc.
    Inventors: Andrew Garst, Michael Graige, Richard Fox, Eileen Spindler, Amy Hiddessen, Phillip Belgrader, Don Masquelier, Bruce Chabansky
  • Publication number: 20210246441
    Abstract: The present disclosure relates to methods and compositions to enable use of editing cassettes for nucleic-acid guided editing and then repurposing the cassettes to increase targeted sequencing efficiency and reduce sequencing costs of the edited genomes.
    Type: Application
    Filed: February 3, 2021
    Publication date: August 12, 2021
    Inventors: Paul Hardenbol, Kara Juneau, Michael Graige
  • Publication number: 20210002628
    Abstract: The present disclosure methods for identifying binding partners using cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of peptides that bind to targets of interest. The engineered peptides are preferably expressed in the cells under conditions that provide both secretion and display of the engineered peptides on the cell surfaces, thus providing access of the engineered peptides to identify potential binding pairs. The cell libraries cab be engineered using an automated editing system that provides for one or more targeted edits per cell.
    Type: Application
    Filed: August 9, 2020
    Publication date: January 7, 2021
    Inventors: Stephen Federowicz, Deanna Church, Michael Graige